Search Results - "Wollring, Michael M"

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas by Wollring, Michael M., Werner, Jan-Michael, Ceccon, Garry, Lohmann, Philipp, Filss, Christian P., Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert

“…PET imaging using radiolabeled amino acids in addition to MRI has become a valuable diagnostic tool in the clinical management of patients with brain tumors…”
Get full text

PET imaging of gliomas: Status quo and quo vadis? by Galldiks, Norbert, Lohmann, Philipp, Friedrich, Michel, Werner, Jan-Michael, Stetter, Isabelle, Wollring, Michael M, Ceccon, Garry, Stegmayr, Carina, Krause, Sandra, Fink, Gereon R, Law, Ian, Langen, Karl-Josef, Tonn, Joerg-Christian

“…PET imaging, particularly using amino acid tracers, has become a valuable adjunct to anatomical MRI in the clinical management of patients with glioma…”
Get full text

MRI and 18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis by Rosen, Jurij, Werner, Jan-Michael, Ceccon, Garry S, Rosen, Elena K, Wollring, Michael M, Stetter, Isabelle, Lohmann, Philipp, Mottaghy, Felix M, Fink, Gereon R, Langen, Karl-Josef, Galldiks, Norbert

“…PET using the radiolabeled amino acid O-(2-[18F]fluoroethyl)-l-tyrosine (18F-FET) has been shown to be of value for treatment monitoring in patients with brain…”
Get full text

Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET by Wollring, Michael M, Werner, Jan-Michael, Bauer, Elena K, Tscherpel, Caroline, Ceccon, Garry S, Lohmann, Philipp, Stoffels, Gabriele, Kabbasch, Christoph, Goldbrunner, Roland, Fink, Gereon R, Langen, Karl-Josef, Galldiks, Norbert

“…Abstract Background We evaluated O-(2-[18F]fluoroethyl)-l-tyrosine (FET) PET and MRI for early response assessment in recurrent glioma patients treated with…”
Get full text

Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib by Werner, Jan-Michael, Wollring, Michael M, Tscherpel, Caroline, Rosen, Elena K, Werr, Lisa, Stetter, Isabelle, Rueß, Daniel, Ruge, Maximilian I, Brunn, Anna, Al Shughri, Abdulkader, Kabbasch, Christoph, Fink, Gereon R, Langen, Karl-Josef, Galldiks, Norbert

Get full text

MRI and 18 F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis by Rosen, Jurij, Werner, Jan-Michael, Ceccon, Garry S., Rosen, Elena K., Wollring, Michael M., Stetter, Isabelle, Lohmann, Philipp, Mottaghy, Felix M., Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert

Get full text

NIMG-16. ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET by Werner, Jan-Michael, Wollring, Michael M, Tscherpel, Caroline, Rosen, Elena K, Ceccon, Garry, Stetter, Isabelle, Lohmann, Philipp, Weller, Johannes, Stoffels, Gabriele, Baues, Christian, Celik, Eren, Mottaghy, Felix M, Goldbrunner, Roland, Herrlinger, Ulrich, Fink, Gereon R, Langen, Karl-Josef, Galldiks, Norbert

“…Abstract BACKGROUND We examined the value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for early response assessment in patients with newly diagnosed…”
Get full text

NIMG-84. PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RECURRENCE USING MRI AND FET PET by Wollring, Michael M, Werner, Jan-Michael, Bauer, Elena, Tscherpel, Caroline, Lohmann, Philipp, Stoffels, Gabriele, Kabbasch, Christoph, Goldbrunner, Roland, Fink, Gereon, Langen, Karl-Josef, Galldiks, Norbert

“…Abstract BACKGROUND This study evaluates O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET and contrast-enhanced MRI for early response assessment in glioma patients…”
Get full text

MRI and 18 F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis by Rosen, Jurij, Werner, Jan-Michael, Ceccon, Garry S, Rosen, Elena K, Wollring, Michael M, Stetter, Isabelle, Lohmann, Philipp, Mottaghy, Felix M, Fink, Gereon R, Langen, Karl-Josef, Galldiks, Norbert

“…PET using the radiolabeled amino acid -(2-[ F]fluoroethyl)-l-tyrosine ( F-FET) has been shown to be of value for treatment monitoring in patients with brain…”
Get full text

NIMG-84. PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RECURRENCE USING MRI AND FET PET by Wollring, Michael M, Werner, Jan-Michael, Bauer, Elena, Tscherpel, Caroline, Lohmann, Philipp, Stoffels, Gabriele, Kabbasch, Christoph, Goldbrunner, Roland, Fink, Gereon, Langen, Karl-Josef, Galldiks, Norbert

Get full text